Fulltext

Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1

Sprott, H. ; Glatzel, M. ; Michel, B. A.

In: Rheumatology, 2004, vol. 43, no. 4, p. 524-526

Ajouter à la liste personnelle
    Titre
    • Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1
    Auteur
    • Sprott, H.. Department of Rheumatology and Institute of Physical Medicine, University Hospital Zurich and
    • Glatzel, M.. Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland
    • Michel, B. A.. Department of Rheumatology and Institute of Physical Medicine, University Hospital Zurich and
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:303744